Abeona Therapeutics Officer Lists 9,191 Shares for Sale

The notice also records 24,880 shares sold during the preceding three months for an aggregate market value of $173,257.

Rhea-AI Filing Summary

Abeona Therapeutics Inc. (ABEO) officer Joseph Walter Vazzano reported a proposed sale of 9,191 common shares, listed at an aggregate market value of $47,385, with an approximate sale date of September 29, 2026. The securities table separately lists 18,186 common shares acquired from the issuer as restricted stock awards on September 29, 2026. The remarks state that the shares listed for sale were sold to cover taxes pursuant to an RSA vesting event.

Key Figures

Common shares reported for sale: 9,191 shares Aggregate market value of shares reported for sale: $47,385 Restricted stock awards acquired: 18,186 shares +3 more

6 metrics

Common shares reported for sale 9,191 shares Approximate sale date September 29, 2026

Aggregate market value of shares reported for sale $47,385 Shares reported for sale

Restricted stock awards acquired 18,186 shares Acquired from the issuer on September 29, 2026

Shares sold during the past three months 24,880 shares Reported for July 9, 2026

Aggregate market value of shares sold during the past three months $173,257 Reported for July 9, 2026

Issuer shares outstanding 57,184,017 shares Number of shares outstanding listed in the securities-to-be-sold table

Key Terms

Rule 144, Restricted Stock Awards, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Awards financial

"Nature of acquisition: Restricted Stock Awards"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ABEO shares did Joseph Walter Vazzano report for sale?

The notice lists 9,191 common shares for sale, at an aggregate market value of $47,385, with an approximate sale date of September 29, 2026.

Why were the ABEO shares being sold?

The remarks state that the shares listed for sale were sold to cover taxes pursuant to an RSA vesting event. The securities table separately lists 18,186 common shares acquired from the issuer as restricted stock awards on September 29, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 04:55 PM Accepted by SEC EDGAR 09/29/2026 - 04:54 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001715291
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABEONA THERAPEUTICS INC.
SEC File Number	001-15771
Address of Issuer	6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OHIO 44103
Phone	646-813-4701
Name of Person for Whose Account the Securities are To Be Sold	Vazzano Joseph Walter
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	9191	47385.00	57184017	09/29/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/29/2026	Restricted Stock Awards	Issuer			18186	09/29/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joseph Vazzano 6555 CARNEGIE AVE 4TH FLOOR CLEVELAND OH 44103	Common Stock	07/09/2026	24880	173257.00

144: Remarks and Signature

Remarks	These shares were sold to cover for taxes pursuant to an RSA vesting event.
Date of Notice	09/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Azad Daswani, as a duly authorized representative of STIFEL, as attorney-in-fact for Joseph Vazzano
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)